201 related articles for article (PubMed ID: 36451854)
1. Adoptive therapy with amyloid-β specific regulatory T cells alleviates Alzheimer's disease.
Yang H; Park SY; Baek H; Lee C; Chung G; Liu X; Lee JH; Kim B; Kwon M; Choi H; Kim HJ; Kim JY; Kim Y; Lee YS; Lee G; Kim SK; Kim JS; Chang YT; Jung WS; Kim KH; Bae H
Theranostics; 2022; 12(18):7668-7680. PubMed ID: 36451854
[No Abstract] [Full Text] [Related]
2. Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer's disease model.
Baek H; Ye M; Kang GH; Lee C; Lee G; Choi DB; Jung J; Kim H; Lee S; Kim JS; Lee HJ; Shim I; Lee JH; Bae H
Oncotarget; 2016 Oct; 7(43):69347-69357. PubMed ID: 27713140
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-β specific regulatory T cells attenuate Alzheimer's disease pathobiology in APP/PS1 mice.
Yeapuri P; Machhi J; Lu Y; Abdelmoaty MM; Kadry R; Patel M; Bhattarai S; Lu E; Namminga KL; Olson KE; Foster EG; Mosley RL; Gendelman HE
Mol Neurodegener; 2023 Dec; 18(1):97. PubMed ID: 38111016
[TBL] [Abstract][Full Text] [Related]
4. CD4+ effector T cells accelerate Alzheimer's disease in mice.
Machhi J; Yeapuri P; Lu Y; Foster E; Chikhale R; Herskovitz J; Namminga KL; Olson KE; Abdelmoaty MM; Gao J; Quadros RM; Kiyota T; Jingjing L; Kevadiya BD; Wang X; Liu Y; Poluektova LY; Gurumurthy CB; Mosley RL; Gendelman HE
J Neuroinflammation; 2021 Nov; 18(1):272. PubMed ID: 34798897
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's disease.
Faridar A; Vasquez M; Thome AD; Yin Z; Xuan H; Wang JH; Wen S; Li X; Thonhoff JR; Zhao W; Zhao H; Beers DR; Wong STC; Masdeu JC; Appel SH
Acta Neuropathol Commun; 2022 Sep; 10(1):144. PubMed ID: 36180898
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Effects of Aβ-Specific Regulatory T Cells in Alzheimer's Disease: A Study in 5xFAD Mice.
Park SY; Yang J; Yang H; Cho I; Kim JY; Bae H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255856
[TBL] [Abstract][Full Text] [Related]
7. Blocking Microglial Proliferation by CSF-1R Inhibitor Does Not Alter the Neuroprotective Effects of Adoptive Regulatory T Cells in 3xTg Alzheimer's Disease Mice.
Park SY; Cha N; Kim S; Chae S; Lee WJ; Jung H; Bae H
Curr Issues Mol Biol; 2024 Mar; 46(4):2871-2883. PubMed ID: 38666910
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells decrease C3-positive reactive astrocytes in Alzheimer-like pathology.
Stym-Popper G; Matta K; Chaigneau T; Rupra R; Demetriou A; Fouquet S; Dansokho C; Toly-Ndour C; Dorothée G
J Neuroinflammation; 2023 Mar; 20(1):64. PubMed ID: 36890536
[TBL] [Abstract][Full Text] [Related]
9. A Therapeutic Nanovaccine that Generates Anti-Amyloid Antibodies and Amyloid-specific Regulatory T Cells for Alzheimer's Disease.
Jung M; Lee S; Park S; Hong J; Kim C; Cho I; Sohn HS; Kim K; Park IW; Yoon S; Kwon S; Shin J; Lee D; Kang M; Go S; Moon S; Chung Y; Kim Y; Kim BS
Adv Mater; 2023 Jan; 35(3):e2207719. PubMed ID: 36329674
[TBL] [Abstract][Full Text] [Related]
10. Bee venom phospholipase A2 ameliorates Alzheimer's disease pathology in Aβ vaccination treatment without inducing neuro-inflammation in a 3xTg-AD mouse model.
Baek H; Lee CJ; Choi DB; Kim NS; Kim YS; Ye YJ; Kim YS; Kim JS; Shim I; Bae H
Sci Rep; 2018 Nov; 8(1):17369. PubMed ID: 30478329
[TBL] [Abstract][Full Text] [Related]
11. Chlorzoxazone exhibits neuroprotection against Alzheimer's disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo.
Bai Y; Ma X
Int Immunopharmacol; 2020 Nov; 88():106790. PubMed ID: 32795892
[TBL] [Abstract][Full Text] [Related]
12. Far infrared light irradiation enhances Aβ clearance via increased exocytotic microglial ATP and ameliorates cognitive deficit in Alzheimer's disease-like mice.
Li Q; Peng J; Luo Y; Zhou J; Li T; Cao L; Peng S; Zuo Z; Wang Z
J Neuroinflammation; 2022 Jun; 19(1):145. PubMed ID: 35701825
[TBL] [Abstract][Full Text] [Related]
13. Development of Beta-Amyloid-Specific CAR-Tregs for the Treatment of Alzheimer's Disease.
Saetzler V; Riet T; Schienke A; Henschel P; Freitag K; Haake A; Heppner FL; Buitrago-Molina LE; Noyan F; Jaeckel E; Hardtke-Wolenski M
Cells; 2023 Aug; 12(16):. PubMed ID: 37626926
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of ex vivo-expanded regulatory T cells on trimethyltin-induced neurodegeneration in mice.
Park SY; Yang H; Ye M; Liu X; Shim I; Chang YT; Bae H
J Neuroinflammation; 2022 Jun; 19(1):143. PubMed ID: 35690816
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer's disease.
Ye M; Chung HS; Lee C; Yoon MS; Yu AR; Kim JS; Hwang DS; Shim I; Bae H
J Neuroinflammation; 2016 Jan; 13():10. PubMed ID: 26772975
[TBL] [Abstract][Full Text] [Related]
16. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
17. CSB6B prevents β-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-κB and NLRP3 in microglia cells.
Yan S; Xuan Z; Yang M; Wang C; Tao T; Wang Q; Cui W
Int Immunopharmacol; 2020 Apr; 81():106263. PubMed ID: 32028243
[TBL] [Abstract][Full Text] [Related]
18. Influenza vaccination in early Alzheimer's disease rescues amyloidosis and ameliorates cognitive deficits in APP/PS1 mice by inhibiting regulatory T cells.
Yang Y; He Z; Xing Z; Zuo Z; Yuan L; Wu Y; Jiang M; Qi F; Yao Z
J Neuroinflammation; 2020 Feb; 17(1):65. PubMed ID: 32075657
[TBL] [Abstract][Full Text] [Related]
19. Imbalance of Circulating T
Oberstein TJ; Taha L; Spitzer P; Hellstern J; Herrmann M; Kornhuber J; Maler JM
Front Immunol; 2018; 9():1213. PubMed ID: 29915582
[TBL] [Abstract][Full Text] [Related]
20. Treatment with glatiramer acetate in APPswe/PS1dE9 mice at an early stage of Alzheimer's disease prior to amyloid-beta deposition delays the disease's pathological development and ameliorates cognitive decline.
Huang Z; Gong Z; Lin Y; Yang F; Chen W; Xiang S; Huang Y; Xiao H; Xu S; Duan J
Front Aging Neurosci; 2024; 16():1267780. PubMed ID: 38352237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
